The Immune Co., which operates as MoldCo, is a digital health platform providing virtual care for mold-related illness and environmental toxin exposure. Its clinical focus includes chronic inflammatory response syndrome (CIRS) and related inflammatory conditions. Care is delivered through telehealth consultations with mold-trained healthcare providers and is described as expert-led and evidence-based, with an emphasis on personalised treatment planning for a patient group the company regards as underserved.
The company's diagnostic offering spans blood testing, genetic testing and environmental assessment. The Starter Panel and Complete Panel measure biomarkers associated with inflammation and immune disruption caused by mold exposure; the Complete Panel examines 16 key blood markers. Genetic predisposition testing is used to assess susceptibility to mold toxicity, while the HERTSMI-2 kit allows patients to test for mold exposure in the home.
Treatment follows a patented three-step recovery protocol - Detox, Clear, Repair - built on three decades of Dr. Ritchie Shoemaker's research. Prescriptions are prepared by pharmacies and shipped directly to patients, alongside at-home testing kits. The service operates virtually across the United States.
The company cites U.S. figures indicating that roughly half of homes show signs of dampness or mold, that around one in four individuals are genetically unable to detoxify mold properly, and that millions of Americans are affected. The founder, Ariana Thacker, established the mission after personally experiencing the health effects of toxic mold exposure.
